75 Wu J, Sheng C, Liu Z, et al. Lmx1a enhances the effect of iNSCs in a PD model. Stem Cell Res, 2015, 14: 1-9
[2]
8 Ren X, Zhang T, Gong X, et al. AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model. Exp Neurol, 2013, 248: 148-156
[3]
9 Sun Z, Jia J, Gong X, et al. Inhibition of glutamate and acetylcholine release in behavioral improvement induced by electroacupuncture in parkinsonian rats. Neurosci Lett, 2012, 520: 32-37
[4]
10 Lindvall O, Rehncrona S, Brundin P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson''s disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol, 1989, 46: 615-631
[5]
11 Svendsen C N, Caldwell M A, Shen J, et al. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson''s disease. Exp Neurol, 1997, 148: 135-146
[6]
12 Brederlau A, Correia A S, Anisimov S V, et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson''s disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells, 2006, 24: 1433-1440
[7]
13 Tabar V, Tomishima M, Panagiotakos G, et al. Therapeutic cloning in individual parkinsonian mice. Nat Med, 2008, 14: 379-381
[8]
14 Sanchez-Pernaute R, Lee H, Patterson M, et al. Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson''s disease. Brain, 2008, 131: 2127-2139
[9]
15 Hargus G, Cooper O, Deleidi M, et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA, 2010, 107: 15921-15926
[10]
16 Brundin P, Nilsson O G, Strecker R E, et al. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson''s disease. Exp Brain Res, 1986, 65: 235-240
[11]
17 Wenning G K, Odin P, Morrish P, et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson''s disease. Ann Neurol, 1997, 42: 95-107
[12]
18 Hagell P, Schrag A, Piccini P, et al. Sequential bilateral transplantation in Parkinson''s disease: effects of the second graft. Brain, 1999, 122: 1121-1132
[13]
19 Politis M, Wu K, Loane C, et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson''s patients with neural transplants. Sci Transl Med, 2010, 2: 38ra46
[14]
20 Freed C R, Greene P E, Breeze R E, et al. Transplantation of embryonic dopamine neurons for severe Parkinson''s disease. New Engl J Med, 2001, 344: 710-719
[15]
21 Olanow C W, Kordower J H, Freeman T B. Fetal nigral transplantation as a therapy for Parkinson''s disease. Trends Neurosci, 1996, 19: 102-109
[16]
22 Olanow C W, Goetz C G, Kordower J H, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson''s disease. Ann Neurol, 2003, 54: 403-414
[17]
23 Hagell P, Piccini P, Bjorklund A, et al. Dyskinesias following neural transplantation in Parkinson''s disease. Nat Neurosci, 2002, 5: 627-628
[18]
24 Piccini P, Pavese N, Hagell P, et al. Factors affecting the clinical outcome after neural transplantation in Parkinson''s disease. Brain, 2005, 128: 2977-2986
[19]
25 Politis M, Oertel W H, Wu K, et al. Graft-induced dyskinesias in Parkinson''s disease: high striatal serotonin/dopamine transporter ratio. Mov Disord, 2011, 26: 1997-2003
[20]
26 Gage F H, Kempermann G, Palmer T D, et al. Multipotent progenitor cells in the adult dentate gyrus. J Neurobiol, 1998, 36: 249-266
[21]
27 Altman J, Das G D. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol, 1965, 124: 319-335
[22]
28 Mckay R. Stem cells in the central nervous system. Science, 1997, 276: 66-71
[23]
29 Alvarez-Buylla A, Temple S. Stem cells in the developing and adult nervous system. J Neurobiol, 1998, 36: 105-110
[24]
30 Nishino H, Hida H, Takei N, et al. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum. Exp Neurol, 2000, 164: 209-214
[25]
31 Parish C L, Castelo-Branco G, Rawal N, et al. Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J Clin Invest, 2008, 118: 149-160
[26]
32 Fricker R A, Carpenter M K, Winkler C, et al. Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci, 1999, 19: 5990-6005
[27]
33 Schwarz S C, Wittlinger J, Schober R, et al. Transplantation of human neural precursor cells in the 6-OHDA lesioned rats: effect of immunosuppression with cyclosporine A. Parkinsonism Relat Disord, 2006, 12: 302-308
[28]
34 Evans M J, Kaufman M H. Establishment in culture of pluripotential cells from mouse embryos. Nature, 1981, 292: 154-156
[29]
35 Thomson J A, Kalishman J, Golos T G, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci USA, 1995, 92: 7844-7848
[30]
36 Thomson J A, Itskovitz-Eldor J, Shapiro S S, et al. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282: 1145-1147
[31]
51 Stadtfeld M, Nagaya M, Utikal J, et al. Induced pluripotent stem cells generated without viral integration. Science, 2008, 322: 945-949
[32]
52 Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science, 2009, 324: 797-801
[33]
53 Cheng L, Hansen N F, Zhao L, et al. Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell, 2012, 10: 337-344
[34]
54 Chung C Y, Khurana V, Auluck P K, et al. Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science, 2013, 342: 983-987
[35]
55 Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells, 2001, 19: 180-192
[36]
56 Zipori D. Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair. Blood Cells Mol Dis, 2004, 33: 211-215
[37]
57 Trzaska K A, Rameshwar P. Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells. Methods Mol Biol, 2011, 698: 295-303
[38]
58 Dezawa M, Kanno H, Hoshino M, et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest, 2004, 113: 1701-1710
[39]
59 Ren Z, Wang J, Wang S, et al. Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys. Sci Rep, 2013, 3: 2786
[40]
60 Vierbuchen T, Ostermeier A, Pang Z P, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature, 2010, 463: 1035-1041
[41]
61 Ieda M, Fu J D, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell, 2010, 142: 375-386
[42]
62 Szabo E, Rampalli S, Risueno R M, et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature, 2010, 468: 521-526
[43]
63 Pfisterer U, Kirkeby A, Torper O, et al. Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci USA, 2011, 108: 10343-10348
[44]
64 Caiazzo M, Dell''anno M T, Dvoretskova E, et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature, 2011, 476: 224-227
[45]
65 Kim J, Su S C, Wang H, et al. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell, 2011, 9: 413-419
[46]
66 Sheng C, Zheng Q, Wu J, et al. Generation of dopaminergic neurons directly from mouse fibroblasts and fibroblast-derived neural progenitors. Cell Res, 2012, 22: 769-772
[47]
67 Liu X, Li F, Stubblefield E A, et al. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res, 2012, 22: 321-332
[48]
68 Kim J, Efe J A, Zhu S, et al. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci USA, 2011, 108: 7838-7843
[49]
69 Sheng C, Zheng Q, Wu J, et al. Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors. Cell Res, 2012, 22: 208-218
[50]
70 Wang L, Huang W, Su H, et al. Generation of integration-free neural progenitor cells from cells in human urine. Nat Methods, 2013, 10: 84-89
[51]
71 Zou Q, Yan Q, Zhong J, et al. Direct conversion of human fibroblasts into neuronal restricted progenitors. J Biol Chem, 2014, 289: 5250-5260
[52]
72 Kim S M, Flasskamp H, Hermann A, et al. Direct conversion of mouse fibroblasts into induced neural stem cells. Nat Protoc, 2014, 9: 871-881
[53]
73 Cheng L, Hu W, Qiu B, et al. Generation of neural progenitor cells by chemical cocktails and hypoxia. Cell Res, 2014, 24: 665-679
[54]
74 Hong J Y, Lee S H, Lee S C, et al. Therapeutic potential of induced neural stem cells for spinal cord injury. J Biol Chem, 2014, 289: 32512-32525
[55]
1 Olanow C W. The scientific basis for the current treatment of Parkinson''s disease. Annu Rev Med, 2004, 55: 41-60
[56]
2 Dick F D, De Palma G, Ahmadi A, et al. Environmental risk factors for Parkinson''s disease and parkinsonism: the Geoparkinson study. Occup Environ Med, 2007, 64: 666-672
[57]
3 Lees A J, Hardy J, Revesz T. Parkinson''s disease. Lancet, 2009, 373: 2055-2066
[58]
4 Fahn S, Oakes D, Shoulson I, et al. Levodopa and the progression of Parkinson''s disease. New Engl J Med, 2004, 351: 2498-2508
[59]
5 Marsden C D, Parkes J D. "On-off" effects in patients with Parkinson''s disease on chronic levodopa therapy. Lancet, 1976, 1: 292-296
[60]
6 Benabid A L, Chabardes S, Mitrofanis J, et al. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson''s disease. Lancet Neurol, 2009, 8: 67-81
[61]
7 Bensadoun J C, Deglon N, Tseng J L, et al. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson''s disease using GDNF. Exp Neurol, 2000, 164: 15-24
[62]
37 Kim J H, Auerbach J M, Rodriguez-Gomez J A, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson''s disease. Nature, 2002, 418: 50-56
[63]
38 Roy N S, Cleren C, Singh S K, et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med, 2006, 12: 1259-1268
[64]
39 Kriks S, Shim J W, Piao J, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson''s disease. Nature, 2011, 480: 547-551
[65]
40 Lee S H, Lumelsky N, Studer L, et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol, 2000, 18: 675-679
[66]
41 Kawasaki H, Mizuseki K, Nishikawa S, et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron, 2000, 28: 31-40
[67]
42 Chambers S M, Fasano C A, Papapetrou E P, et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol, 2009, 27: 275-280
[68]
43 Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126: 663-676
[69]
44 Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 131: 861-872
[70]
45 Yu J, Vodyanik M A, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318: 1917-1920
[71]
46 Liu H, Zhu F, Yong J, et al. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell, 2008, 3: 587-590
48 Dimos J T, Rodolfa K T, Niakan K K, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 2008, 321: 1218-1221
[74]
49 Israel M A, Yuan S H, Bardy C, et al. Probing sporadic and familial Alzheimer''s disease using induced pluripotent stem cells. Nature, 2012, 482: 216-220
[75]
50 Wernig M, Lengner C J, Hanna J, et al. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol, 2008, 26: 916-924
